Publicacions en col·laboració amb investigadors/es de University of Gothenburg (26)

2010

  1. Clinical staging in the pathophysiology of psychotic and affective disorders: Facilitation of prognosis and treatment

    Neurotoxicity Research, Vol. 18, Núm. 3-4, pp. 211-228

  2. Epigenetics and biomarkers in the staging of neuropsychiatric disorders

    Neurotoxicity Research, Vol. 18, Núm. 3-4, pp. 347-366

  3. Staging perspectives in neurodevelopmental aspects of neuropsychiatry: Agents, phases and ages at expression

    Neurotoxicity Research, Vol. 18, Núm. 3-4, pp. 287-305

2008

  1. Affective status in relation to impulsive, motor and motivational symptoms: Personality, development and physical exercise

    Neurotoxicity Research, Vol. 14, Núm. 2-3, pp. 151-168

  2. Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: Executive functions and locus of control

    Neurotoxicity Research, Vol. 14, Núm. 2-3, pp. 205-225

  3. Focusing on symptoms rather than diagnoses in brain dysfunction: Conscious and nonconscious expression in impulsiveness and decision-making

    Neurotoxicity Research, Vol. 14, Núm. 1, pp. 1-20

  4. Schizopsychotic symptom-profiles and biomarkers: Beacons in diagnostic labyrinths

    Neurotoxicity Research, Vol. 14, Núm. 2-3, pp. 79-96

2007

  1. Comorbidity implications in brain disease: Neuronal substrates of symptom profiles

    Neurotoxicity Research, Vol. 12, Núm. 1, pp. 1-15

  2. Comorbidity of substance abuse with other psychiatric disorders

    Neurotoxicity Research, Vol. 12, Núm. 1, pp. 17-27

  3. Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry

    Neurotoxicity Research, Vol. 12, Núm. 1, pp. 29-42

  4. Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders

    Neurotoxicity Research, Vol. 12, Núm. 1, pp. 43-60

2004

  1. Gene-environment interplay in affect and dementia: Emotional modulation of cognitive expression in personal outcomes

    Neurotoxicity Research, Vol. 6, Núm. 3, pp. 159-173

  2. Gene-environment interplay in alcoholism and other substance abuse disorders: Expressions of heritability and factors influencing vulnerabilities

    Neurotoxicity Research, Vol. 6, Núm. 5, pp. 343-361

  3. Gene-environment interplay in neurogenesis and neurodegeneration

    Neurotoxicity Research, Vol. 6, Núm. 6, pp. 415-434

  4. Gene-environment interplay in schizopsychotic disorders

    Neurotoxicity Research, Vol. 6, Núm. 1, pp. 1-9

2003

  1. Brain sites of movement disorder: Genetic and environmental agents in neurodevelopmental perturbations

    Neurotoxicity Research, Vol. 5, Núm. 1-2, pp. 1-26

  2. Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment

    Neurotoxicity Research, Vol. 5, Núm. 1-2, pp. 95-109

2002

  1. Functional deficits following neonatal dopamine depletion and isolation housing: Circular water maze acquisition under pre-exposure conditions and motor activity

    Neurotoxicity Research, Vol. 4, Núm. 5-6, pp. 503-522

  2. Neonatal 6-hydroxydopamine-induced hypo/hyperactivity: Blockade by dopamine reuptake inhibitors and effect of acute D-amphetamine

    Neurotoxicity Research, Vol. 4, Núm. 3, pp. 247-266

  3. Neurodevelopment liabilities of substance abuse

    Neurotoxicity Research, Vol. 4, Núm. 4, pp. 267-279